118 related articles for article (PubMed ID: 3545851)
1. High doses of metoclopramide or droperidol in the prevention of cisplatin-induced emesis.
Saller R; Hellenbrecht D
Eur J Cancer Clin Oncol; 1986 Oct; 22(10):1199-203. PubMed ID: 3545851
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the antiemetic efficacy of two high-dose benzamides, metoclopramide and alizapride, against cisplatin-induced emesis.
Saller R; Hellenbrecht D
Cancer Treat Rep; 1985 Nov; 69(11):1301-3. PubMed ID: 3912040
[TBL] [Abstract][Full Text] [Related]
3. Dose-response relationships of the objective and subjective antiemetic effects and of different side effects of metoclopramide against cisplatin induced emesis.
Hellenbrecht D; Saller R
Arzneimittelforschung; 1986 Dec; 36(12):1845-9. PubMed ID: 3566848
[TBL] [Abstract][Full Text] [Related]
4. [Benefit and risk of high-dose metoclopramide in comparison to high-dose haloperidol or triflupromazine in cisplatin-induced vomiting].
Saller R; Hellenbrecht D
Klin Wochenschr; 1985 May; 63(9):428-32. PubMed ID: 4039775
[TBL] [Abstract][Full Text] [Related]
5. Antiemetic efficacy of high-dose corticosteroids and droperidol in cisplatin-induced emesis: a controlled trial with droperidol and metoclopramide.
Donovitz GS; O'Quinn AG; Smith ML
Gynecol Oncol; 1984 Jul; 18(3):320-5. PubMed ID: 6540222
[TBL] [Abstract][Full Text] [Related]
6. Double-blind crossover trial of droperidol, metoclopramide, and prochlorperazine as antiemetics in cisplatin therapy.
Lewis GO; Bernath AM; Ellison NM; Gallagher JG; Porter PA; Rine KT
Clin Pharm; 1984; 3(6):618-21. PubMed ID: 6391784
[TBL] [Abstract][Full Text] [Related]
7. High-dose metoclopramide + lorazepam versus low-dose metoclopramide + lorazepam + dehydrobenzperidol in the treatment of cisplatin-induced nausea and vomiting.
Herrstedt J; Hannibal J; Hallas J; Andersen E; Laursen LC; Hansen M
Ann Oncol; 1991 Mar; 2(3):223-7. PubMed ID: 2043493
[TBL] [Abstract][Full Text] [Related]
8. Antiemetic efficacy of prochlorperazine, haloperidol, and droperidol in cisplatin-induced emesis.
Owens NJ; Schauer AR; Nightingale CH; Golub GR; Martin RS; Williams HM; Schauer PK
Clin Pharm; 1984; 3(2):167-70. PubMed ID: 6373102
[TBL] [Abstract][Full Text] [Related]
9. Comparison of four antiemetic regimens for the treatment of cisplatin-induced vomiting.
Póka R; Hernádi Z; Juhász B; Lampé L
Int J Gynaecol Obstet; 1993 Jul; 42(1):19-24. PubMed ID: 8103470
[TBL] [Abstract][Full Text] [Related]
10. [Antiemetic effects of combinations of metoclopramide, droperidol and dexamethasone for the prevention of cisplatin-induced gastro-intestinal toxicity: a randomized crossover trial].
Fujii M; Kiura K; Kamei H; Okabe K; Toki H
Gan To Kagaku Ryoho; 1987 Jul; 14(7):2257-61. PubMed ID: 3300561
[TBL] [Abstract][Full Text] [Related]
11. Oral medium-dosed metoclopramide versus placebo as highly effective antiemetic prophylaxis in in- and outpatients on noncisplatin chemotherapy.
Vogt C; Hellenbrecht D; Saller R; Achtert G; Brockmann P; Hausleiter H
Oncology; 1993; 50(2):81-5. PubMed ID: 8451040
[TBL] [Abstract][Full Text] [Related]
12. A comparison of metoclopramide vs. droperidol/phenobarbital for emesis induced by chemotherapy.
Gumbart CH; Sorensen SH; Bickers JN
Am J Med Sci; 1987 Feb; 293(2):90-3. PubMed ID: 3565458
[TBL] [Abstract][Full Text] [Related]
13. Improved benefit/risk ratio of higher-dose metoclopramide therapy during cisplatin-induced emesis.
Saller R; Hellenbrecht D; Hellstern A; Hess H
Eur J Clin Pharmacol; 1985; 29(3):311-2. PubMed ID: 4076327
[TBL] [Abstract][Full Text] [Related]
14. Combination antiemetics for cisplatin chemotherapy.
Sridhar KS; Donnelly E
Cancer; 1988 Apr; 61(8):1508-17. PubMed ID: 3280112
[TBL] [Abstract][Full Text] [Related]
15. Comparison of ondansetron with metoclopramide in prevention of acute emesis associated with low dose & high dose cisplatin chemotherapy.
Bhatia A; Tripathi KD; Sharma M
Indian J Med Res; 2003 Jul; 118():33-41. PubMed ID: 14748464
[TBL] [Abstract][Full Text] [Related]
16. Metoclopramide. A review of antiemetic trials.
Gralla RJ
Drugs; 1983 Feb; 25 Suppl 1():63-73. PubMed ID: 6682376
[TBL] [Abstract][Full Text] [Related]
17. Comparison of oral 5-HT3-receptor antagonists and low-dose oral metoclopramide plus i.m. dexamethasone for the prevention of delayed emesis in head and neck cancer patients receiving high-dose cisplatin.
Mantovani G; Macciò A; Curreli L; Lampis B; Ghiani M; Bianchi A; Contu P
Oncol Rep; 1998; 5(1):273-80. PubMed ID: 9458381
[TBL] [Abstract][Full Text] [Related]
18. High-dose metoclopramide and chlorpromazine in the treatment of cisplatin-induced emesis.
Aasebø U; Slørdal L; Prytz PS; Aarbakke J
Pharmacol Toxicol; 1987 May; 60(5):337-9. PubMed ID: 3303001
[TBL] [Abstract][Full Text] [Related]
19. [Randomized crossover trial of the antiemetic effects obtained with metoclopramide and droperidol versus those obtained with metoclopramide, droperidol and methylprednisolone in patients receiving cis-platinum chemotherapy].
Fujii M; Kiura K; Tamai M; Okabe K; Toki H
Gan To Kagaku Ryoho; 1986 Aug; 13(8):2562-7. PubMed ID: 3527070
[TBL] [Abstract][Full Text] [Related]
20. A randomized trial of high dose bolus metoclopramide versus low-dose continuous infusion metoclopramide in the prevention of cisplatin-induced emesis.
Dana BW; McDermott M; Everts E; Abdulhay G
Am J Clin Oncol; 1987 Jun; 10(3):253-6. PubMed ID: 3296733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
